pharma news today obesity drugs glp-1 september 2025 FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes Pharma Giants Bet on Next-Generation

Countries across the world are witnessing a surge in demand, particularly for drugs like semaglutide, which are widely used for weight loss

An agonist , in medical terms , is a manufactured substance that attaches to a cell receptor and causes the same action as the hormone

Exendin-4 (5 g/kg or 1 and 10 nM) inhibited high mobility group box I protein expression, a proinflammatory mediator, in myocardial ischemia and reperfusion in rats [72] and in high glucose-induced myocardial cell injury [73]

1 Engs paper, published in the Journal of Biological Chemistry , noted something strange: exendin-4 shared 53% of its amino acid sequence with a human gut hormone called glucagon-like peptide-1 (GLP-1), which had been characterized just a few years earlier